Medical Oncologist
Metastatic breast cancer
What happens when hormone therapy stops working?
Endocrine resistance means a hormone-sensitive breast cancer keeps growing despite hormone therapy. It is most often discussed in metastatic disease. It does not mean all options are gone: other hormone treatments, targeted combinations and chemotherapy usually remain. This page explains what resistance means and what comes next.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What does it mean when hormone therapy stops working?
- Early and later resistance, in general terms
- Treatment options after hormone therapy stops working
- The vocabulary, in plain language
- Honest expectations
- Resistance and early breast cancer
- Coping when your treatment needs to change
- How your team decides the cancer is growing
- Questions to ask when treatment needs to change
- What people assume about hormone therapy resistance
- Common questions about endocrine resistance
The short answer
What does it mean when hormone therapy stops working?
Endocrine resistance means a hormone-sensitive breast cancer has found ways to keep growing despite hormone therapy. Some cancers are resistant from the start; others respond well for years and then adapt. It is most often discussed in metastatic breast cancer, when scans show the cancer growing on a hormone tablet. Resistance does not mean all options are gone. There are usually further hormone treatments, targeted drugs that work alongside them, and chemotherapy to consider.
How cancers become resistant
Cancer cells can change the hormone receptor itself, switch on other growth pathways, or rely less on oestrogen. Some of these changes can be detected with tests, which helps choose the next treatment.
What usually happens next
Your oncologist reviews how long the previous treatment worked, how the cancer is behaving, your symptoms and test results, and then suggests a different hormone approach, a combination with a targeted drug, or chemotherapy.
When chemotherapy may come sooner
If the cancer is growing quickly, affecting organs such as the liver significantly, or causing serious symptoms, chemotherapy may be preferred because it tends to act faster.
This page gives general information only. Your next treatment is planned with your oncologist.Two patterns
Early and later resistance, in general terms
Resistance early on
Resistance after a good response
Cancer grows soon after starting treatment
Cancer controlled for a long time, then grows
Hormones may play a smaller role
Hormones often still matter
Other treatments may be considered sooner
Another hormone approach often tried
Testing for other pathways is important
Testing still helps choose the next step
Next steps
Treatment options after hormone therapy stops working
The choice depends on previous treatment, test results and how the cancer is behaving.
A different hormone treatment
Switching to another class of hormone therapy, such as a drug that breaks down the oestrogen receptor, can still work.
Hormone therapy with a targeted drug
CDK4/6 inhibitors, and drugs aimed at the PI3K or mTOR pathways, can overcome some resistance when combined with hormone therapy.
Some depend on mutation tests.Chemotherapy
Used when the cancer needs a faster response or when hormone approaches have been exhausted.
Newer treatments and trials
Antibody-drug treatments, newer oral hormone drugs and clinical trials may be options for some women.
Tests that may guide choices
- PIK3CA mutation testing
- ESR1 mutation testing
- BRCA and HER2-low status
Not sure whether this applies to you?
Ask an oncologistWords you will hear
The vocabulary, in plain language
- Endocrine resistance
- When a hormone-sensitive cancer grows despite hormone therapy.
- Progression
- The cancer growing or spreading on treatment.
- ESR1 mutation
- A change in the oestrogen receptor gene that can cause resistance to some hormone tablets.
- PIK3CA mutation
- A change in a growth pathway gene that can be targeted with specific drugs.
- Liquid biopsy
- A blood test that looks for tumour DNA, sometimes used to find mutations.
- Line of treatment
- Each new treatment used after the previous one stops working.
Being straight with you
Honest expectations
Hearing that treatment has stopped working is hard, and it often brings fear that nothing else can be done. In reality, hormone-sensitive metastatic breast cancer frequently has several further lines of treatment available, and many women continue to live well for a long time.
Each step may work for a shorter time
Later treatments often control the cancer for less time than the first ones did. This is a general pattern rather than a rule, and some women respond well to later lines.
Tests can open doors
Testing the cancer, or a blood sample, for specific mutations can reveal treatments that might otherwise be missed. Ask whether such tests are appropriate for you.
Quality of life stays central
Choosing the next treatment involves weighing effectiveness against side effects and how you want to live. Your priorities should shape the plan.
What this page cannot tell you
It cannot tell you which treatment comes next for you. Ask your oncologist what options remain and what each aims to achieve.
Talk to our team
Have a question about your situation?
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Early breast cancer
Resistance and early breast cancer
Resistance is mostly discussed in metastatic disease, but it also matters for women treated for early breast cancer.
Recurrence during or after hormone therapy
If cancer returns while a woman is still taking hormone tablets, or soon after finishing, this suggests some resistance. It guides which treatment is chosen next.
Before surgery
When hormone therapy is given before surgery, a cancer that does not shrink may be less hormone-sensitive than expected, prompting a change of plan.
Why it does not mean earlier treatment was wasted
Hormone therapy lowers the chance of recurrence for most women, even if some cancers eventually adapt. The years of protection still matter.
Coping
Coping when your treatment needs to change
A change in treatment can bring back the fear and uncertainty of the original diagnosis. It helps to know that this is a common experience.
Ask for a clear explanation
Ask your oncologist to explain what the scans show, why a change is recommended, and what the new treatment involves day to day.
Bring support
Having a family member or friend at appointments where results are discussed helps you take in information and ask questions.
Consider extra support
Palliative care teams, counsellors and support groups can help with symptoms, emotions and practical matters alongside active treatment.
Recognising it
How your team decides the cancer is growing
Deciding that hormone therapy has stopped working is not based on a single test. Your oncologist brings together several pieces of information before recommending a change.
Scans over time
Regular scans compare the size and number of areas of cancer with earlier images. Small changes can be difficult to interpret, so a repeat scan is sometimes arranged before deciding.
Symptoms
New or worsening pain, breathlessness, tiredness or loss of appetite can point to growth. Tell your team about any change between appointments, rather than waiting for the next scan.
Blood tests
Tumour markers and liver or bone blood tests can add useful clues, but a rise alone does not always mean the treatment has failed. They are read alongside scans and symptoms.
Choosing the next step
Questions to ask when treatment needs to change
A clear conversation helps you understand the choice and feel part of it.
About the options
Ask which treatments are possible now, why one is recommended over another, and whether any tests on the cancer or blood could open further options.
About daily life
Ask how the new treatment is taken, how often you will need to visit, what side effects to expect, and how they will be managed.
About the future
Ask how the team will know whether the new treatment is working, and what might come after it if needed. Knowing there is a plan often eases anxiety.
Commonly believed
What people assume about hormone therapy resistance
If one hormone tablet stops working, none will.
Different hormone treatments work in different ways, and combinations with targeted drugs can overcome some resistance.
Resistance means I did something wrong.
Resistance is a biological change in the cancer, not the result of anything you did.
Chemotherapy is always the next step.
Often another hormone-based approach comes first, unless the cancer needs a faster response.
Mutation tests are only for research.
Some tests directly guide treatment choices today. Ask whether they are appropriate for you.
Questions we are asked
Common questions about endocrine resistance
How do doctors know hormone therapy has stopped working?
Usually through scans showing growth, new symptoms, and sometimes rising tumour markers. Your oncologist looks at the whole picture before deciding to change treatment.
Can resistance be prevented?
Not reliably. Taking treatment regularly and adding targeted drugs where recommended can delay it for some women.
Do I need a new biopsy?
Sometimes. A biopsy of a metastasis can show whether receptors have changed. A blood test may also look for mutations.
How long will the next treatment work?
It varies widely. Your oncologist can give a general idea based on your situation.
Are clinical trials an option?
Trials for endocrine-resistant breast cancer are common. Ask whether any are suitable.
Will the new treatment have more side effects?
Some combinations and chemotherapy have more side effects than hormone tablets alone. Your team will explain what to expect.
Can I get a second opinion?
Yes. Many women seek another view when treatment changes. Bring your scans, reports and treatment history.
Who can help with symptoms?
Your oncology team and palliative care specialists can help with pain, tiredness and other symptoms alongside treatment.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Warangal
Vizag
Talk to our team
Speak to a breast cancer specialist
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Sources
- European Society for Medical Oncology — Metastatic breast cancer clinical practice guideline
- National Cancer Institute — Breast cancer treatment (PDQ)
- Breast Cancer Now — Treatment for secondary breast cancer
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.